Chemomaker System at SIFO 2024: A New Era in Safe, Efficient IV Compounding
The ChemoMaker® System is a result of a strategic collaboration between Biovalley Investments & Partners (BIP), the legal manufacturer and global distributor, and Engmotion d.o.o., a technical development partner and fabricator specializing in medical and pharmaceutical automation. With over two decades of engineering expertise, Engmotion has contributed significantly to the design and development of advanced solutions for the automated preparation of cytostatic drugs and antibiotics, tailored for hospital pharmacies. This expertise has shaped ChemoMaker®into a high-performing, streamlined automated system that enhances technician efficiency and elevates safety standards in hospital compounding workflows.
See more on Chemomaker System. Contact us for a Demo
Global Recognition and Growing Interest
Recently presented by BIP at SIFO 2024, the ChemoMaker® attracted significant attention from pharmaceutical professionals and hospital pharmacies across Italy. UFA operators were especially impressed by ChemoMaker® unique advantages—its compact design, flexibility, and speed in injectable preparation. These qualities set ChemoMaker® apart, especially when compared to larger, more complex robotic systems. The system compactness, automation, and adaptability within existing workflows make it a highly favorable choice, fitting seamlessly even into traditional containment hoods.
Key Features Driving Chemomaker’s Success
- Flexibility and Speed: Designed to streamline the compounding process, ChemoMaker® delivers rapid, precise preparation with easy and swift configuration change ideal for busy hospital settings.
- Process Safety: The ChemoMaker® ensures accurate and secure and contamination-free preparations, protecting operators while maintaining a high standard of care.
- Ease of Integration: With dimensions optimized for laminar flow hood or isolator, ChemoMaker® adapts effortlessly into existing hospital workflows, enhancing efficiency without the need for extensive modifications.
Ongoing Innovation and Future-Ready
2025 is set to be a landmark year for ChemoMaker®, with exciting new optional features like multi-bag preparation and an optional CSTD circuit, addressing evolving industry needs. This forward-thinking design allows operators to upgrade the ChemoMaker® as new technologies emerge, ensuring its place as a crucial asset for hospitals prioritizing automation and safety.
The growing interest, including prominent institutions such as the Hospital Pharmacy of Cremona, underscores the ChemoMaker® role as a transformative solution for IV compounding. As we look toward the future, ChemoMaker® is poised to be the trusted partner for hospitals worldwide, where accuracy, efficiency, adaptability, and safety remain paramount.2025 is set to be a landmark year for Chemomaker, with exciting new optional features like multi-bag preparation and an optional CSTD circuit, addressing evolving industry needs. This forward-thinking design allows operators to upgrade the Chemomaker as new technologies emerge, ensuring its place as a crucial asset for hospitals prioritizing automation and safety.
The growing interest, including prominent institutions such as the Hospital Pharmacy of Cremona, underscores the ChemoMaker® role as a transformative solution for IV compounding. As we look toward the future, ChemoMaker® is poised to be the trusted partner for hospitals worldwide, where accuracy, efficiency, adaptability, and safety remain paramount.2025 is set to be a landmark year for Chemomaker, with exciting new optional features like multi-bag preparation and an optional CSTD circuit, addressing evolving industry needs. This forward-thinking design allows operators to upgrade the Chemomaker as new technologies emerge, ensuring its place as a crucial asset for hospitals prioritizing automation and safety.
